Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 162.83 -1.73 (-1.05%) Streaming Delayed Price Updated: 1:56 PM EDT, May 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about AbbVie < Previous 1 2 3 4 5 6 7 Next > AbbVie Tracking for New Highs in 2024 May 07, 2024 Future Dividend King AbbVie is tracking for new highs as the shift away from Humira-based business gains momentum with new treatments and acquisitions. Via MarketBeat Topics Earnings Exposures Financial MarketBeat Week in Review – 4/29 - 5/3 May 04, 2024 Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 Via MarketBeat Topics Economy Stocks Exposures Interest Rates US Equities Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher April 30, 2024 After falling nearly 6% based on concerns about Humira sales, AbbVie stock is recovering, and bullish analyst sentiment is likely to push the stock higher Via MarketBeat Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors April 12, 2024 From Glancy Prongay & Murray LLP Via Business Wire AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning February 16, 2024 Via Investor Brand Network AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning February 07, 2024 Via Investor Brand Network INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors April 12, 2024 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors April 10, 2024 From The Law Offices of Frank R. Cruz Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN) April 01, 2024 From Brodsky & Smith LLC Via GlobeNewswire AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning January 24, 2024 Via Investor Brand Network AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action January 02, 2024 Via Investor Brand Network BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE) March 25, 2024 From Brodsky & Smith LLC Via GlobeNewswire Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer March 24, 2024 Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence The Next Great Biotech Boom Has Arrived March 19, 2024 EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END Via FinancialNewsMedia AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action December 22, 2023 Via Investor Brand Network Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END Via FinancialNewsMedia Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea February 27, 2024 From Healis Therapeutics Via GlobeNewswire Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 From FN Media Group LLC Via GlobeNewswire Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032 February 15, 2024 EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END Via FinancialNewsMedia Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032 February 15, 2024 From FN Media Group LLC Via GlobeNewswire AbbVie turns a corner; patent cliff fears were overblown February 02, 2024 AbbVie's patent cliff is already a thing of the past with Skyrizi and Rinvoq outperforming and other assets also strong. Dividends are safe, growth is back. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate January 29, 2024 Via Get News Exposures Product Safety BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq – January 29, 2024 From Brodsky & Smith LLC Via GlobeNewswire Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate January 29, 2024 New York, Jan. 29, 2024 - (Plato Data) -- Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug... Via TheNewswire.com Exposures Product Safety BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire AbbVie continues shopping spree with biotech buyout December 12, 2023 While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend. Via MarketBeat BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. December 11, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR) December 04, 2023 From Brodsky & Smith LLC Via GlobeNewswire Doing Your Holiday Shopping? These Stocks Might Make Great Gifts December 04, 2023 No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet. Via MarketBeat Topics Bonds Exposures Debt Markets < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.